Health Science Center, Shenzhen University, Shenzhen, China.
Department of Trauma and Orthopedics, The 2nd Affiliated Hospital of Shenzhen University, The Affiliated Baoan Hospital of Southern Medical University, Shenzhen, China.
Pharm Biol. 2021 Dec;59(1):1181-1190. doi: 10.1080/13880209.2021.1967410.
The traditional medicine 2036 Specialty-Qiangxin recipe (2036S-QXR) has been widely used in China to improve cardiac function, prevent stroke, and strengthen the immune system. However, its long-term toxicity remains unknown.
The present study evaluates the long-term toxicity of 2036S-QXR in rats.
2036S-QXR (0.6, 1.2, and 2.4 g/kg body weight per day) was orally administered for 26 weeks to Wistar rats, while the rats in the control group received distilled water. The effects on urinary, hematological, biochemical, and histopathological parameters were investigated during the study period.
No significant changes in all tested parameters were observed in the 0.6 and 1.2 g/kg groups, compared with the control group ( < 0.05). Higher levels of alanine aminotransferase (46.00 ± 12.85 25.40 ± 3.36) and aspartate aminotransferase (152.40 ± 32.52 111.40 ± 18.78) were observed after 13 weeks in the female rats in the 2.4 g/kg group compared with the control group ( < 0.05), but these returned to the control levels after the recovery period ( > 0.05). Several cases displayed the presence of urine protein (3/7 males and 3/7 females) and mild lesions in the kidney (10/20) and thymus (5/20) in the 2.4 g/kg group, without significant changes compared with the control group ( > 0.05).
The present study shows that 2036S-QXR does not cause long-term toxicity, supporting its therapeutic use. To further determine the optimal doses, future studies should test more doses and include more animals in each group.
传统医学 2036 年强心灵方(2036S-QXR)已在中国广泛用于改善心脏功能、预防中风和增强免疫系统。然而,其长期毒性尚不清楚。
本研究评估 2036S-QXR 在大鼠中的长期毒性。
2036S-QXR(0.6、1.2 和 2.4 g/kg 体重/天)口服给予 Wistar 大鼠 26 周,对照组给予蒸馏水。在研究期间,观察对尿液、血液学、生化和组织病理学参数的影响。
与对照组相比(<0.05),0.6 和 1.2 g/kg 组的所有测试参数均无明显变化。与对照组相比,2.4 g/kg 组的雌性大鼠在第 13 周时丙氨酸氨基转移酶(46.00±12.85比 25.40±3.36)和天冬氨酸氨基转移酶(152.40±32.52比 111.40±18.78)升高,但在恢复期后恢复至对照组水平(>0.05)。2.4 g/kg 组有 3/7 只雄性和 3/7 只雌性大鼠出现尿蛋白(3/7 雄性和 3/7 雌性),20 只大鼠中有 10 只肾脏(10/20)和 5 只胸腺(5/20)出现轻度病变,但与对照组相比无明显变化(>0.05)。
本研究表明,2036S-QXR 不会引起长期毒性,支持其治疗用途。为了进一步确定最佳剂量,未来的研究应该测试更多剂量,并在每个组中包含更多的动物。